HTG Molecular Diagnostics (NASDAQ:HTGM) announced its earnings results on Wednesday. The medical research company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.08, Fidelity Earnings reports. HTG Molecular Diagnostics had a negative net margin of 76.97% and a negative return on equity of 88.60%.

NASDAQ:HTGM opened at $0.34 on Thursday. The firm has a market cap of $20.32 million, a P/E ratio of -0.58 and a beta of 1.33. The company has a current ratio of 5.21, a quick ratio of 5.07 and a debt-to-equity ratio of 0.34. The stock’s 50 day simple moving average is $0.49 and its 200-day simple moving average is $0.67. HTG Molecular Diagnostics has a 12-month low of $0.30 and a 12-month high of $3.24.

A number of analysts recently weighed in on HTGM shares. ValuEngine upgraded shares of HTG Molecular Diagnostics from a “hold” rating to a “buy” rating in a research note on Tuesday, March 3rd. HC Wainwright reissued a “buy” rating and set a $2.00 price objective on shares of HTG Molecular Diagnostics in a research report on Tuesday, January 21st. Finally, Zacks Investment Research upgraded shares of HTG Molecular Diagnostics from a “sell” rating to a “hold” rating in a research note on Tuesday, March 17th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. HTG Molecular Diagnostics presently has a consensus rating of “Buy” and a consensus price target of $3.13.

HTG Molecular Diagnostics Company Profile

HTG Molecular Diagnostics, Inc a commercial stage life sciences company, focuses on the precision medicine. The company offers instrumentation (or platforms); consumables comprising assay kits; and software analytics that automate sample processing and profiles various molecular targets. Its platforms generate a molecular profiling library for detection using next-generation sequencing.

Featured Story: What moving averages are used to define a golden cross?

Earnings History for HTG Molecular Diagnostics (NASDAQ:HTGM)

Receive News & Ratings for HTG Molecular Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HTG Molecular Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.